MedPath

Bristol-Myers Squibb Pharma Company

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

39

PPB:39

Drug Approvals

KRAZATI TABLETS 200MG

Approval Date
Dec 18, 2024
PPB

CAMZYOS CAPSULES 2.5MG

Approval Date
Dec 8, 2023
PPB

CAMZYOS CAPSULES 15MG

Approval Date
Dec 8, 2023
PPB

CAMZYOS CAPSULES 10MG

Approval Date
Dec 8, 2023
PPB

CAMZYOS CAPSULES 5MG

Approval Date
Dec 8, 2023
PPB

SOTYKTU TABLETS 6MG

Approval Date
Oct 20, 2023
PPB

ONUREG TABLETS 200MG

Approval Date
Sep 4, 2023
PPB

ONUREG TABLETS 300MG

Approval Date
Sep 4, 2023
PPB

OPDIVO CONCENTRATE FOR SOLUTION FOR INFUSION 240MG/24ML

Approval Date
Feb 9, 2023
PPB

REBLOZYL POWDER FOR SOLUTION FOR INJECTION 75MG

Approval Date
Feb 23, 2022
PPB
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.